Drug intelligence / Profile preview

fish oil enriched with eicosapentaenoic acid

Development stage
Unknown
Administration
Oral
01

Overview

Fish oil enriched with eicosapentaenoic acid (EPA) is a formulation of fish oil in which the concentration of the omega-3 fatty acid EPA is significantly higher than in standard fish oil preparations. EPA-enriched fish oil is used primarily as a **dietary supplement** and has also been studied in pharmaceutical preparations for cardiovascular risk reduction and hypertriglyceridemia. The main mechanism involves EPA's ability to lower triglyceride levels, reduce risk of cardiovascular events, and exert anti-inflammatory effects. Fish oil enriched with EPA is different from pharmaceutical icosapent ethyl (which is pure ethyl-EPA) but may be sold as concentrated dietary supplements or as medical-grade nutrition. The product may vary by manufacturer but is typically obtained from cold-water fish oils, specifically processed to increase EPA content relative to docosahexaenoic acid (DHA)[2][5]. EPA acts by multiple mechanisms, including inhibition of hepatic very-low-density lipoprotein (VLDL) synthesis/secretion and enhanced triglyceride clearance, reduction in platelet aggregation, modulation of inflammation, and altered membrane fatty acid composition[1][3][4].

Other names
fish oil EPA-enrichedEPA-enriched fish oil
02

Targets

GNA11 (Guanine nucleotide-binding protein subunit alpha-11)

Beyond the preview

Go deeper on fish oil enriched with eicosapentaenoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fish oil enriched with eicosapentaenoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call